Telix Pharmaceuticals (OTCMKTS:TLPPF) Trading Up 0.1% – Here’s What Happened

Telix Pharmaceuticals Limited (OTCMKTS:TLPPF) shares traded up 0.1% on Monday . The stock traded as high as $9.75 and last traded at $9.75. 155 shares were traded during mid-day trading, a decline of 96% from the average session volume of 3,787 shares. The stock had previously closed at $9.74.

Telix Pharmaceuticals Trading Up 0.1%

The firm has a fifty day simple moving average of $9.62 and a 200 day simple moving average of $8.62.

Telix Pharmaceuticals Company Profile

Telix Pharmaceuticals is a molecularly targeted radiopharmaceutical company specializing in the development and commercialisation of diagnostic and therapeutic products for oncology and rare diseases. The company leverages radioisotopes conjugated to disease-specific targeting agents, enabling precise imaging and treatment of cancerous lesions. Telix’s portfolio includes investigational imaging compounds, such as a gallium-68-labeled prostate cancer agent, alongside therapeutic candidates that deliver beta- or alpha-emitting isotopes directly to disease sites.

Telix’s lead diagnostic program focuses on positron emission tomography (PET) imaging for prostate cancer, designed to improve detection and staging accuracy.